ICD Co. Ltd (040910) - Net Assets
Based on the latest financial reports, ICD Co. Ltd (040910) has net assets worth ₩93.82 Billion KRW (≈ $63.58 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩154.82 Billion ≈ $104.92 Million USD) and total liabilities (₩60.99 Billion ≈ $41.33 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 040910 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩93.82 Billion |
| % of Total Assets | 60.6% |
| Annual Growth Rate | -0.76% |
| 5-Year Change | -45.96% |
| 10-Year Change | 6.71% |
| Growth Volatility | 16.52 |
ICD Co. Ltd - Net Assets Trend (2013–2024)
This chart illustrates how ICD Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore ICD Co. Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for ICD Co. Ltd (2013–2024)
The table below shows the annual net assets of ICD Co. Ltd from 2013 to 2024. For live valuation and market cap data, see market value of ICD Co. Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩96.98 Billion ≈ $65.72 Million |
-23.75% |
| 2023-12-31 | ₩127.18 Billion ≈ $86.19 Million |
-17.01% |
| 2022-12-31 | ₩153.25 Billion ≈ $103.85 Million |
-8.75% |
| 2021-12-31 | ₩167.94 Billion ≈ $113.81 Million |
-6.43% |
| 2020-12-31 | ₩179.47 Billion ≈ $121.63 Million |
+22.05% |
| 2019-12-31 | ₩147.06 Billion ≈ $99.66 Million |
+11.92% |
| 2018-12-31 | ₩131.40 Billion ≈ $89.05 Million |
-2.04% |
| 2017-12-31 | ₩134.14 Billion ≈ $90.91 Million |
+19.03% |
| 2016-12-31 | ₩112.69 Billion ≈ $76.37 Million |
+24.00% |
| 2015-12-31 | ₩90.88 Billion ≈ $61.59 Million |
-13.79% |
| 2013-12-31 | ₩105.42 Billion ≈ $71.44 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ICD Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 27.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩35.76 Billion | 36.87% |
| Common Stock | ₩9.29 Billion | 9.58% |
| Other Components | ₩51.94 Billion | 53.55% |
| Total Equity | ₩96.98 Billion | 100.00% |
ICD Co. Ltd Competitors by Market Cap
The table below lists competitors of ICD Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hotel Mandarine Regency Tbk PT
JK:HOME
|
$65.08 Million |
|
Sambo Motors Co. Ltd
KQ:053700
|
$65.08 Million |
|
ADYTON RESOURCES CORP.
F:701
|
$65.09 Million |
|
Elin Electronics Limited
NSE:ELIN
|
$65.09 Million |
|
Future Health Esg Corp
NASDAQ:FHLT
|
$65.06 Million |
|
Shanghai Yaohua Pilkington Glass Group Co Ltd B
SHG:900918
|
$65.06 Million |
|
Northwest Copper Corp
V:NWST
|
$65.06 Million |
|
Ferronordic AB (publ)
ST:FNM
|
$65.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ICD Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 127,183,134,380 to 96,982,617,760, a change of -30,200,516,620 (-23.7%).
- Net loss of 28,290,711,620 reduced equity.
- Other factors decreased equity by 1,909,805,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-28.29 Billion | -29.17% |
| Other Changes | ₩-1.91 Billion | -1.97% |
| Total Change | ₩- | -23.75% |
Book Value vs Market Value Analysis
This analysis compares ICD Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.84x to 0.99x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩7014.66 | ₩5880.00 | x |
| 2017-12-31 | ₩8328.47 | ₩5880.00 | x |
| 2018-12-31 | ₩8347.70 | ₩5880.00 | x |
| 2019-12-31 | ₩8919.35 | ₩5880.00 | x |
| 2020-12-31 | ₩10655.15 | ₩5880.00 | x |
| 2021-12-31 | ₩10289.00 | ₩5880.00 | x |
| 2022-12-31 | ₩9697.59 | ₩5880.00 | x |
| 2023-12-31 | ₩7849.88 | ₩5880.00 | x |
| 2024-12-31 | ₩5945.71 | ₩5880.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ICD Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -29.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -19.17%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 1.97x
- Recent ROE (-29.17%) is below the historical average (1.71%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 6.85% | 8.91% | 0.65x | 1.18x | ₩-3.32 Billion |
| 2015 | 0.29% | 1.58% | 0.14x | 1.31x | ₩-8.82 Billion |
| 2016 | 9.19% | 4.48% | 0.96x | 2.14x | ₩-915.35 Million |
| 2017 | 18.26% | 7.85% | 1.32x | 1.76x | ₩11.08 Billion |
| 2018 | 22.70% | 12.75% | 1.22x | 1.46x | ₩16.69 Billion |
| 2019 | 7.58% | 9.17% | 0.60x | 1.39x | ₩-3.55 Billion |
| 2020 | 18.64% | 10.83% | 1.33x | 1.30x | ₩15.51 Billion |
| 2021 | 0.45% | 0.66% | 0.50x | 1.39x | ₩-16.03 Billion |
| 2022 | -3.54% | -3.59% | 0.75x | 1.32x | ₩-20.74 Billion |
| 2023 | -32.49% | -66.35% | 0.30x | 1.62x | ₩-54.04 Billion |
| 2024 | -29.17% | -19.17% | 0.77x | 1.97x | ₩-37.99 Billion |
Industry Comparison
This section compares ICD Co. Ltd's net assets metrics with peer companies in the Electronic Components industry.
Industry Context
- Industry: Electronic Components
- Average net assets among peers: $218,334,830,115
- Average return on equity (ROE) among peers: 5.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ICD Co. Ltd (040910) | ₩93.82 Billion | 6.85% | 0.65x | $65.07 Million |
| YoungPoong (000670) | $471.92 Billion | 0.00% | 1.01x | $822.21 Million |
| Sam Hwa Capaci (001820) | $22.52 Billion | 31.89% | 1.98x | $467.29 Million |
| Samick Music I (002450) | $144.58 Billion | 1.50% | 1.43x | $64.41 Million |
| Hansol Technics (004710) | $34.25 Billion | 0.00% | 5.26x | $173.10 Million |
| Sunny Elec (004770) | $30.06 Billion | 0.40% | 0.10x | $43.99 Million |
| Samyoung Elec (005680) | $363.17 Billion | 5.47% | 0.12x | $197.81 Million |
| PJ Electronics Co. Ltd (006140) | $109.57 Billion | 4.53% | 0.33x | $71.73 Million |
| Isupetasys (007660) | $168.70 Billion | 12.06% | 1.02x | $7.48 Billion |
| Korea Circuit Co. Ltd. (007810) | $128.70 Billion | 2.46% | 0.61x | $1.51 Billion |
| Korea Circuit Co Ltd (007815) | $709.89 Billion | -5.16% | 0.74x | $43.40 Million |
About ICD Co. Ltd
ICD Co., Ltd. engages in the manufacture and sale of AMOLED, LCD, and semiconductor equipment in South Korea and internationally. The company offers DRY etcher and research-thermal evaporator. It also involves in bio and medical business by using plasma to develop devices and products for sterilization, medicine, cosmetics, etc. The company was founded in 2000 and is headquartered in Anseong-si, … Read more